Company intelligence / Profile preview

ESI

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

ESI Ultrapure is a leading supplier of high-quality products and tailored solutions supporting the biopharmaceutical industry in Ireland and the UK. The company specializes in single-use assemblies manufactured in ISO Class 7 cleanrooms. It does not develop drugs but enables efficient GMP-compliant production through its engineering expertise and distribution partnerships with global manufacturers.

Modalities: Single-use assemblies and componentsBioprocess equipment and consumables
Industry: Chemicals & Materials

Partnerships

EmersonFlowserveCraneITTMillipore/Merck KGaAAlfa LavalParker Hannifin

Beyond the preview

Go deeper on ESI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ESI.

Explore the full profile